Financials

  • Market Capitalization 351.79 M
  • Employee 533
  • Founded 2002
  • CEO N/A
  • Website www.vandapharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000HT5MG6
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.7
Fiyat/satışlar oranı
1.88

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3193
PRLD
Prelude Therapeutics Incorporated - Common Stock
4.46 USD+1.59%-13.23%+6.19%+443.90%355.22 M USD
3199
PALI
Palisade Bio, Inc. - Common Stock
2.03 USD+5.18%-3.33%+13.41%+19.41%352.37 M USD
3212
FATE
Fate Therapeutics, Inc. - Common Stock
2.99 USD0.00%-0.33%+58.20%+164.60%348.51 M USD
3225
ZNTL
Zentalis Pharmaceuticals, Inc. - common stock
4.78 USD+0.21%-1.24%+35.41%+243.88%340.27 M USD

Haberler